CVS Health Files 2024 10-K
Ticker: CVS · Form: 10-K · Filed: 2025-02-12T00:00:00.000Z
Sentiment: neutral
Topics: 10-K, annual-report, healthcare
TL;DR
CVS Health filed its 2024 10-K, detailing financials and operations for the year ending Dec 31, 2024.
AI Summary
CVS Health Corp. filed its 2024 10-K on February 12, 2025, reporting on its fiscal year ending December 31, 2024. The company, previously known as CVS Caremark Corp., is incorporated in Delaware and headquartered in Woonsocket, RI. This filing provides a comprehensive overview of the company's financial performance and business operations for the past fiscal year.
Why It Matters
This 10-K filing is crucial for investors and analysts to understand CVS Health's financial health, strategic direction, and potential risks for the upcoming year.
Risk Assessment
Risk Level: medium — 10-K filings inherently carry medium risk due to the detailed financial and operational information that can impact stock price.
Key Numbers
- 20241231 — Fiscal Year End (Reporting period for the 10-K)
- 20250212 — Filing Date (Date the 10-K was submitted to the SEC)
Key Players & Entities
- CVS HEALTH Corp (company) — Filer
- 0000064803 (company) — Central Index Key
- 20241231 (date) — Fiscal Year End
- 20250212 (date) — Filing Date
- WOONSOCKET, RI (location) — Headquarters
FAQ
What is the primary business of CVS Health Corp. as indicated by its SIC code?
The Standard Industrial Classification (SIC) code for CVS Health Corp. is [5912], which corresponds to RETAIL-DRUG STORES AND PROPRIETARY STORES.
When did CVS Health Corp. change its name from CVS Caremark Corp.?
CVS Health Corp. changed its name from CVS CAREMARK CORP on 20070509.
What is the SEC file number for CVS Health Corp.'s 10-K filing?
The SEC file number for CVS Health Corp. is 001-01011.
Where is CVS Health Corp. incorporated?
CVS Health Corp. is incorporated in Delaware (DE).
What is the physical address of CVS Health Corp.'s business operations?
The business address for CVS Health Corp. is ONE CVS DR., WOONSOCKET, RI 02895.
From the Filing
0000064803-25-000007.txt : 20250212 0000064803-25-000007.hdr.sgml : 20250212 20250212064738 ACCESSION NUMBER: 0000064803-25-000007 CONFORMED SUBMISSION TYPE: 10-K PUBLIC DOCUMENT COUNT: 168 CONFORMED PERIOD OF REPORT: 20241231 FILED AS OF DATE: 20250212 DATE AS OF CHANGE: 20250212 FILER: COMPANY DATA: COMPANY CONFORMED NAME: CVS HEALTH Corp CENTRAL INDEX KEY: 0000064803 STANDARD INDUSTRIAL CLASSIFICATION: RETAIL-DRUG STORES AND PROPRIETARY STORES [5912] ORGANIZATION NAME: 07 Trade & Services IRS NUMBER: 050494040 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 10-K SEC ACT: 1934 Act SEC FILE NUMBER: 001-01011 FILM NUMBER: 25611885 BUSINESS ADDRESS: STREET 1: ONE CVS DR. CITY: WOONSOCKET STATE: RI ZIP: 02895 BUSINESS PHONE: 4017651500 MAIL ADDRESS: STREET 1: ONE CVS DR. CITY: WOONSOCKET STATE: RI ZIP: 02895 FORMER COMPANY: FORMER CONFORMED NAME: CVS CAREMARK CORP DATE OF NAME CHANGE: 20070509 FORMER COMPANY: FORMER CONFORMED NAME: CVS/CAREMARK CORP DATE OF NAME CHANGE: 20070322 FORMER COMPANY: FORMER CONFORMED NAME: CVS CORP DATE OF NAME CHANGE: 19970128 10-K 1 cvs-20241231.htm 10-K cvs-20241231 0000064803 2024 FY false http://fasb.org/us-gaap/2024#ProductMember http://fasb.org/us-gaap/2024#ProductMember http://fasb.org/us-gaap/2024#ProductMember P3Y http://fasb.org/us-gaap/2024#PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization http://fasb.org/us-gaap/2024#PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization http://fasb.org/us-gaap/2024#LongTermDebtAndCapitalLeaseObligations http://fasb.org/us-gaap/2024#LongTermDebtAndCapitalLeaseObligations five years five years P3Y P6M iso4217:USD xbrli:shares iso4217:USD xbrli:shares cvs:store cvs:clinic cvs:people cvs:patient cvs:segment cvs:state cvs:business xbrli:pure cvs:member cvs:security cvs:reinsurance_agreement cvs:lease cvs:claim 0000064803 2024-01-01 2024-12-31 0000064803 2024-06-30 0000064803 2025-02-05 0000064803 us-gaap:ProductMember 2024-01-01 2024-12-31 0000064803 us-gaap:ProductMember 2023-01-01 2023-12-31 0000064803 us-gaap:ProductMember 2022-01-01 2022-12-31 0000064803 2023-01-01 2023-12-31 0000064803 2022-01-01 2022-12-31 0000064803 us-gaap:ServiceMember 2024-01-01 2024-12-31 0000064803 us-gaap:ServiceMember 2023-01-01 2023-12-31 0000064803 us-gaap:ServiceMember 2022-01-01 2022-12-31 0000064803 2024-12-31 0000064803 2023-12-31 0000064803 2022-12-31 0000064803 2021-12-31 0000064803 us-gaap:CommonStockMember 2021-12-31 0000064803 us-gaap:TreasuryStockCommonMember 2021-12-31 0000064803 us-gaap:CommonStockIncludingAdditionalPaidInCapitalMember 2021-12-31 0000064803 us-gaap:RetainedEarningsMember 2021-12-31 0000064803 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2021-12-31 0000064803 us-gaap:ParentMember 2021-12-31 0000064803 us-gaap:NoncontrollingInterestMember 2021-12-31 0000064803 us-gaap:RetainedEarningsMember 2022-01-01 2022-12-31 0000064803 us-gaap:ParentMember 2022-01-01 2022-12-31 0000064803 us-gaap:NoncontrollingInterestMember 2022-01-01 2022-12-31 0000064803 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2022-01-01 2022-12-31 0000064803 us-gaap:CommonStockMember 2022-01-01 2022-12-31 0000064803 us-gaap:CommonStockIncludingAdditionalPaidInCapitalMember 2022-01-01 2022-12-31 0000064803 us-gaap:TreasuryStockCommonMember 2022-01-01 2022-12-31 0000064803 us-gaap:CommonStockMember 2022-12-31 0000064803 us-gaap:TreasuryStockCommonMember 2022-12-31 0000064803 us-gaap:CommonStockIncludingAdditionalPaidInCapitalMember 2022-12-31 0000064803 us-gaap:RetainedEarningsMember 2022-12-31 0000064803 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2022-12-31 0000064803 us-gaap:ParentMember 2022-12-31 0000064803 us-gaap:NoncontrollingInterestMember 2022-12-31 0000064803 us-gaap:RetainedEarningsMember 2023-01-01 2023-12-31 0000064803 us-gaap:ParentMember 2023-01-01 2023-12-31 0000064803 us-gaap:NoncontrollingInterestMember 2023-01-01 2023-12-31 0000064803 u